• News
  • SAN DIEGO
  • BioTech

Mast Therapeutics reports 2Q net loss

San Diego-based Mast Therapeutics Inc. (NYSE: MSTX) reported a second quarter net loss of $7.2 million, or $0.06 per share, compared to a net loss of $4.9 million, or $0.09 per share, for the same period in 2013.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Mast Therapeutics Inc.

Company Website

12390 El Camino Real Ste., 150
San Diego, CA 92130

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
MSTX
0.53
  -0.01  
- 1.85%
263,415,000
1.10
0.40

Mast Therapeutics Inc. Executive(s):

Brian Culley

  • Chief Executive Officer

Patrick Keran

  • Chief Operating Officer, President

Brandi Roberts

  • Chief Financial Officer
Subscribe Today!